Psychedelic-assisted psychotherapy (PAP) challenges standard models of clinical research. Treating PAP as a drug-in-context intervention, the paper proposes EBM* as a context-sensitive extension of evidence-based medicine.
Lalumera, E. (2025). Drug-in-context. Evidence, Validity, and the Limits of EBM in Psychedelic Psychotherapy. AZIMUTH, 13(26), 79-100 [10.1400/303333].
Drug-in-context. Evidence, Validity, and the Limits of EBM in Psychedelic Psychotherapy
Elisabetta Lalumera
Primo
2025
Abstract
Psychedelic-assisted psychotherapy (PAP) challenges standard models of clinical research. Treating PAP as a drug-in-context intervention, the paper proposes EBM* as a context-sensitive extension of evidence-based medicine.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
